DEF 14A: Passage Bio, Inc. Sets Date for 2024 Annual Stockholders Meeting
Proxy Statement
Passage Bio, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on May 21, 2024, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.
Summary
- Passage Bio, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 21, 2024, at 9:00 a.m. Eastern Time.
- Stockholders of record as of March 28, 2024, are eligible to vote.
- The meeting's purposes include electing two Class I directors for a three-year term and ratifying the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- The company expects to mail the Notice of Internet Availability of Proxy Materials to stockholders on or about April 9, 2024.
- Stockholders can access the proxy statement and the 2023 Annual Report on Form 10-K at www.ProxyVote.com.
- The Board of Directors recommends voting FOR the election of the Class I directors and FOR the ratification of KPMG LLP's appointment.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, presenting factual information about the upcoming annual meeting and related proposals. The tone is neutral and professional, reflecting a routine corporate communication. The sentiment is slightly positive due to the focus on corporate governance and shareholder engagement.
Positives
- The company is committed to good corporate governance practices.
- The Board of Directors has adopted Corporate Governance Guidelines.
- The company has a Compensation Recovery Policy (Clawback Policy) in place.
- The company has an Insider Trading Policy that prohibits hedging of company stock.
Risks
- The document does not explicitly mention risks, but cybersecurity risk is mentioned as an important component of the company's risk management and compliance program.
Future Outlook
The document outlines the business to be conducted at the annual meeting, including the election of directors and ratification of the independent auditor, but does not provide specific forward-looking statements regarding the company's future financial performance or operations.
Management Comments
- William Chou, M.D, President and Chief Executive Officer, stated that a virtual stockholder meeting provides greater access to those who may want to attend.
- The Board of Directors recommends voting FOR the election of each of the Class I directors and FOR the ratification of the appointment of KPMG LLP.
Industry Context
The document provides standard information related to corporate governance and shareholder meetings, which is typical for publicly traded companies in any industry. The selection of an independent auditor and the election of directors are routine activities.
Comparison to Industry Standards
- The document outlines standard corporate governance practices, such as having an Audit Committee, Compensation Committee, and Nominating and Governance Committee, which is consistent with industry standards for publicly traded companies.
- The director independence criteria align with Nasdaq Stock Market rules and SEC regulations, ensuring independent oversight.
- The engagement of an independent executive compensation consulting firm (Pearl Meyer) to evaluate executive compensation is a common practice among publicly traded companies to ensure fair and competitive compensation packages.
- The adoption of a Compensation Recovery Policy (Clawback Policy) to comply with SEC rules is in line with industry best practices for corporate governance.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Simona King | Kathleen Borthwick | March 1, 2024 | Ms. King's separation from the Company was effective as of July 28, 2023. Ms. Borthwick served as our Senior Vice President and Interim Chief Financial Officer from July 2023 to March 2024. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Adoption of Non-Employee Director Compensation Policy | The Board of Directors adopted a new written Non-Employee Director Compensation Policy covering elements and amounts of compensation for non-employee directors through December 31, 2027. | April 2024 | The policy requires annual analysis of non-employee director compensation by a compensation consultant and sets limitations on compensation amounts. |
| Compensation Recovery Policy (Clawback Policy) | The Board of Directors adopted a Compensation Recovery Policy to comply with new rules and regulations promulgated by the SEC, including Rule 10D-1 of the Exchange Act. | October 12, 2023 | The Clawback Policy allows the company to recover certain incentive-based compensation from Covered Employees in the event of a restatement of financial statements due to material noncompliance with financial reporting requirements. |
Stakeholder Impact
- Shareholders are asked to vote on key proposals, influencing the company's direction.
- Employees are indirectly affected by decisions on executive compensation and company performance.
- The selection of an independent auditor impacts the credibility of financial reporting.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the Annual Meeting on May 21, 2024.
- The company will file the voting results with the SEC in a Current Report on Form 8-K within four business days of the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| March 28, 2024 | Record date for determining stockholders eligible to vote at the Annual Meeting |
| April 9, 2024 | Expected date of mailing the Notice of Internet Availability of Proxy Materials |
| May 20, 2024 | Deadline for submitting votes through the internet or by telephone (11:59 p.m. Eastern Time) |
| May 21, 2024 | Date of the 2024 Annual Meeting of Stockholders |
| December 31, 2024 | Fiscal year end for which KPMG LLP is being considered as the independent accounting firm |
Keywords
proxy statement, annual meeting, directors, KPMG, stockholders, governance, compensation, Passage Bio
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.